Table 3 Etiologies of priapism with associated median durations and priapism subtype classification.
Etiology | Median Duration of Priapism, Hours (IQR) | Acute Ischemic, n (%) | Recurrent Ischemic, n (%) | Nonischemic, n (%) |
|---|---|---|---|---|
Idiopathic (n = 28) | 24 (10–70.5) | 12 (42.9) | 16 (57.1) | 0 (0) |
Intracavernosal injection (ICI) therapy (n = 102) | 6 (4–12) | 77 (75.4) | 25 (24.5) | 0 (0) |
Provider-administered (n = 40) | 3 (2–4) | 39 (97.5) | 1 (2.5) | 0 (0) |
Self-administered, prescribed (n = 40) | 7 (6–12) | 23 (57.5) | 17 (42.5) | 0 (0) |
Self-administered, recreational (n = 22) | 30 (12–63) | 15 (68.2) | 7 (31.8) | 0 (0) |
Medications (n = 42) | 11 (7–48) | 24 (57.1) | 15 (35.7) | 3 (7.1) |
Trazodone (n = 27) | 24 (7.5–48) | 15 (55.6) | 10 (37.0) | 2 (7.4) |
Quetiapine (n = 5) | 8 (6–10) | 2 (40.0) | 2 (40.0) | 1 (20.0) |
Escitalopram (n = 1) | 7 (7–7) | 0 (0) | 1 (100.0) | 0 (0) |
Sildenafil (n = 2) | 29.5 (20.2–38.8) | 1 (50.0) | 1 (50.0) | 0 (0) |
Tadalafil (n = 2) | 13.5 (10.2–16.8) | 1 (50.0) | 1 (50.0) | 0 (0) |
Tamsulosin (n = 2) | 5.5 (5.3–5.8) | 2 (100.0) | 0 (0) | 0 (0) |
Other (n = 3) | N/Aa | 3 (100.0) | 0 (0) | 0 (0) |
Sickle Cell Disease/Trait (n = 7) | 24 (17–480) | 3 (42.9) | 4 (57.1) | 0 (0) |
Illicit Drug Use (n = 3) | 144 (90–156) | 2 (66.7) | 1 (33.3) | 0 (0) |
Trauma (n = 4) | N/Aa | 0 (0) | 0 (0) | 4 (100.0) |
Total | 9.5 (4–36) | 118 (63.4) | 61 (32.8) | 7 (3.8) |
